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        Human memory B cells can be separated into 
four diff  erent CD27  +   B cell populations that 
carry somatic hypermutations (SHMs), namely 
classical isotype-switched B cells, rare IgD-only 
and IgM-only B cells, and an IgM  +  IgD  +   sub-
population (  1  –  4  ). The IgM  +  IgD  +  CD27  +   B cell 
population is also referred to as the IgM mem-
ory pool. Recently, these IgM  +  IgD  +  CD27  +   
cells in the peripheral blood were shown to be 
recirculating marginal zone (MZ) B cells based 
on phenotype and gene expression profi  ling 
(  5, 6  ). Unlike MZ B cells in rodents, human 
MZ B cells are recirculating through the pe-
ripheral blood and do contain SHMs (  7  ). How-
ever, the notion that mouse MZ B cells are 
sessile is challenged by a recent fi  nding that 
mouse MZ B cells shuttle between MZ and fol-
licles, clearly showing that these cells recirculate 
similar as in human (  8  ). MZ B cells participate in 
T cell  –  independent responses to polysaccharide 
antigens and in the initial defense against blood-
borne pathogens (  5, 9  –  11  ). 
  It is unknown when and where IgM  +  IgD  + 
CD27  +   B cells develop. In children under the 
age of 2 yr no response can be detected against 
T-independent infections (  12, 13  ). However, 
IgM  +  IgD  +  CD27  +   B cells are already present 
at birth, albeit at low numbers (  13  ). Whether 
or not IgM  +  IgD  +  CD27  +   B cells are present in 
the fetus is also still unknown. Human MZ B 
cells in the spleen and lymph nodes, as well 
as circulating IgM  +  IgD  +  CD27  +   B cells in the 
peripheral blood and neonatal cord blood, have 
been shown to carry SHMs (  1, 13  –  15  ). Be-
cause no active immune responses are thought 
to happen in the fetus, these data suggest that 
development and induction of SHMs of IgM  + 
IgD  +  CD27  +   B cells are not prompted by an 
active immune response. After the age of 2 yr, 
the frequency of IgM  +  IgD  +  CD27  +   B cells 
in the blood is increased as is the frequency 
of SHMs in these cells (  13  ). This observation 
correlates with the appearance of the anatom-
ical structure of the MZ in the spleen and 
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  IgM  +  IgD  +  CD27  +   B cells from peripheral blood have been described as circulating marginal 
zone B cells. It is still unknown when and where these cells develop. These IgM  +  IgD  +  CD27  +   
B cells exhibit somatic hypermutations (SHMs) in their B cell receptors, but the exact 
nature of the signals leading to induction of these SHMs remains elusive. Here, we show 
that IgM  +  IgD  +  CD27  +   B cells carrying SHMs are observed during human fetal development. 
To examine the role of T cells in human IgM  +  IgD  +  CD27  +   B cell development we used an 
in vivo model in which Rag2      /           C        /      mice were repopulated with human hematopoietic 
stem cells. Using Rag2      /           C        /      mice on a   Nude   background, we demonstrated that 
development and induction of SHMs of human IgM  +  IgD  +  CD27  +   B cells can occur in a T cell  – 
independent manner. 
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average number of mutations in IgM  +  IgD  +  CD27  +   B cells 
that had undergone SHMs was similar to control mice. We 
conclude that both the development of IgM  +  IgD  +  CD27  +   
B cells as well as the induction of SHMs in this cell subset can 
occur in a T cell  –  independent manner. 
    RESULTS   
  IgD  +  CD27  +   B cells are present during human 
fetal development 
  IgM  +  IgD  +  CD27  +   B cells can be detected in neonatal cord 
blood, suggesting that these cells developed before birth. To 
understand when and where these cells developed during 
fetal life, we performed an extensive fl  ow cytometry analysis 
for IgD  +  CD27  +   B cells in the human fetus. The fetal tissue 
used in these experiments ranged from week 14 to 18 of ges-
tation. Adult spleen and neonatal cord blood were used as a 
positive control. IgD  +  CD27  +   B cells were found in fetal cord 
blood, liver, MLNs, spleen, and BM (  Fig. 1 A  ).   Additional 
B cell stainings for surface IgD and CD27 expression in fetal 
tissue are shown in Fig. S1, available at http://www.jem
.org/cgi/content/full/jem.20070447/DC1. The percentages 
of the IgD  +  CD27  +   B cells in the diff  erent organs were on the 
average between 3 and 4.8% of IgD  +   B cells (  Fig. 1 B  ). We 
did not fi  nd signifi  cant diff  erences between the diff  erent fetal 
organs analyzed. In addition, we did not observe signifi  cant 
diff  erences in the frequencies of IgD  +  CD27  +   B cells be-
tween fetuses from gestational week 14 to 18 (Fig. S2). The 
IgD       CD27  +   B cells found in the fetal liver, MLNs, and BM 
were pro  –  /pre  –  B cells based on the expression of CD34 and 
the lack of BCR expression (Fig. S3). This confi  rms the fi  nd-
ings of Vaskova et al. (  25  ) who described transient expression 
of CD27 on early B cells that lack light chain rearrangements 
in human BM. 
  We next determined whether the observed phenotype of 
fetal IgD  +  CD27  +   B cells corresponded to the phenotype of 
MZ B cells using fl  ow cytometry analysis of diff  erent fetal or-
gans and fetal cord blood (  Fig. 1 C  ). In neonatal cord blood, 
the IgD  +  CD27  +   B cells are sIgM  +  CD21  high  CD1c  high  . In fetal 
cord blood and MLNs, the expression of CD21 was compara-
ble to that in control neonatal cord blood. However, ex-
pression of CD21 was lower in the fetal liver, spleen, and BM. 
CD1c expression in neonatal cord blood was similar to that of 
fetal cord blood, MLNs, and spleen. In fetal liver and BM, 
IgD  +  CD27  +   B cells expressed low levels of CD1c. This sug-
gests that the fetal spleen, liver, and BM contain IgD  +  CD27  +   
B cells with a more immature phenotype as compared with 
fetal cord blood and MLNs. The IgD  +  CD27  +   B cell popula-
tion in the fetal spleen appears to be in between these two 
stages. Collectively, our data indicate that the phenotype of 
IgD  +  CD27  +   B cells in fetal cord blood and fetal MLNs is simi-
lar to that in neonatal cord blood. Although sIgM, CD21, and 
CD1c are expressed on IgD  +  CD27  +   B cells in both the fetal 
and adult spleen, the expression levels are diff  erent (  Fig. 1 C  ). 
The biological signifi  cance of the diff  erence in protein ex-
pression is presently unknown. 
  eff  ective humoral immunity against T cell  –  independent in-
fections (  16  ). Thus, IgM  +  IgD  +  CD27  +   B cells in young chil-
dren are formed well before the anatomical structure of 
the MZ is present. The percentage of IgM  +  IgD  +  CD27  +   B 
cells in the blood is reduced in the elderly, correlating with 
a decreased humoral immunity against T cell  –  independent 
infections (  17  ). The spleen has been suggested to be the 
primary organ for IgM  +  IgD  +  CD27  +   B cell development 
because adult asplenic patients have severely decreased IgM  + 
IgD  +  CD27  +   B cell numbers and exhibit poor B cell re-
sponses against T cell  –  independent infections (  6  ). However, 
it is unknown whether the spleen is the site of IgM  +  IgD  + 
CD27  +   B cell development, or whether the spleen sup-
ports the survival to this cell subset in a particularly effi   cient 
manner. It is also unknown how SHMs are induced in IgM  +
  IgD  +  CD27  +   B cells. SHMs are strictly dependent on activa-
tion-induced cytidine deaminase (AID) (  18, 19  ). MZ B cells 
in the spleen do not express the AID protein, as determined 
by immunohistochemistry (  20  ), strongly suggesting that the 
SHM process does not occur in the spleen but at a diff  er-
ent location. 
  Hyper-IgM patients with either CD40 or CD40L defi  -
ciency have IgM  +  IgD  +  CD27  +   B cells but lack classical 
switched memory B cells (  21  ). These patients lack germinal 
centers, in which SHMs are induced in a T cell  –  dependent 
way. In both types of patients, the SHM frequency in the 
IgM  +  IgD  +  CD27  +   B cell population was similar to what is 
seen in healthy donors. Because T cells predominantly acti-
vate CD40 via CD40L expression during a T cell  –  dependent 
germinal center reaction, it has been suggested that the 
development of MZ B cells and the induction of SHMs are 
T cell independent. However, it is conceivable that T cells 
are in fact involved in the development and induction of 
SHMs in a CD40-independent manner. It is important to 
note that the formation of germinal centers can occur in mice 
in the absence of CD40L and CD40, although at a much 
lower level than in wild-type animals (  22  ). Furthermore a 
new CD40 ligand has recently been described in humans, 
C4b binding protein, which binds an activated complement 
component (  23, 24  ). 
  Here, we show that IgM  +  IgD  +  CD27  +   B cells are present 
in the human fetus between weeks 14  –  18 of gestation. These 
cells strongly resemble MZ B cells based on phenotype and 
the presence of SHMs. Furthermore, AID expression could 
be detected in mature B cells from the fetal liver and mesen-
teric lymph nodes (MLNs) but was absent in B cells from 
the spleen and BM, suggesting that SHMs occur in the liver 
and/or MLNs. Using Rag2      /            C        /      mice repopulated with 
human fetal liver CD34  +  CD38        hematopoietic stem cells 
(HSCs), we show that the generation of IgM  +  IgD  +  CD27  +   
B cells is NOTCH2 dependent, supporting the notion that 
these cells are MZ-like B cells. Further experiments in 
Rag2      /            C        /      mice on a   Nude   background, in which T cell 
development cannot occur due to defective thymus develop-
ment, revealed that the generation of human IgM +  IgD  +  CD27  +   
B cells is T cell independent. In the absence of T cells, the JEM VOL. 205, September 1, 2008 
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  The presence of AID in the fetal liver and MLNs may imply 
that the Ig-encoding genes in CD19  +  IgD  +  CD27  +   cells contain 
SHMs. Therefore, CD19  +  IgD  +  CD27  +   and CD19  +  IgD  +  CD27        
cells derived from the fetal spleen were sorted, mRNA was iso-
lated, and an RT-PCR specifi  c for V  H  3-C     was performed. 
Products were cloned into a vector and sequenced. Approx-
imately 20% of the sequences contained SHMs (  Table I  ).   
Collectively, these data show that SHMs are present on fetal 
IgD  +  CD27  +   B cells. 
  Human IgM  +  IgD  +  CD27  +   B cells develop in humanized mice 
and exhibit SHMs 
  To determine whether development of IgD  +  IgM  +  CD27  +   
B cells and induction of SHMs are dependent or independent 
of T cells, we used an in vivo model for human lymphocyte 
development. We and others have set up a human mouse 
  AID expression is detected in the human fetal liver 
and MLNs, and fetal IgD  +  CD27  +   B cells have SHMs 
  A proportion of the CD19  +  IgD  +  CD27  +   B cells derived from 
adult and neonatal cord blood contains AID-driven SHMs 
(  1, 13  ). We examined whether AID was expressed in the dif-
ferent fetal organs. AID expression was detected by RT-PCR 
in mRNA from the fetal liver and MLNs but not from the 
spleen and BM (  Fig. 1 D  ). As expected, AID was detected in 
tonsil mRNA. We extended these fi  ndings by performing 
a semiquantitative RT-PCR for AID on sorted IgD  +   B cells 
from the fetal liver, spleen, and BM (Fig. S4, available at 
http://www.jem.org/cgi/content/full/jem.20070447/DC1). 
Both fetal spleen and fetal BM mature B cells were negative 
for AID expression, whereas fetal liver B cells were positive, 
suggesting that the fetal liver and MLNs are the organs where 
SHMs take place. 
    Figure 1.         Mature B cells with an MZ B cell phenotype are present in the human fetus.   (A) Flow cytometry analysis for CD27 and sIgD of neona-
tal cord blood (CB), fetal cord blood, liver, MLNs, spleen, and BM. Dot plots presented are gated on CD19  +   cells. (B) Percentages of CD27  +   cells within the 
CD19  + sIgD +   gate (fetal cord blood,   n   = 16; fetal liver,   n   = 18; fetal MLNs,   n   = 25; fetal spleen,   n   = 47; fetal BM,   n   = 45). (C) Flow cytometry analysis for 
sIgM, CD12, and CD1c of the CD19  + sIgD + CD27       cells (thin line) and CD19  + sIgD + CD27 +   cells (bold line) using gates indicated in A. Dotted lines represent 
the staining with the matched isotype control. (D) RT-PCR for AID expression in fetal MLNs, liver, spleen, and BM. Adult tonsil was used as a positive con-
trol. Fetal liver B cells were enriched for B cells by CD19 MACS isolation because after Ficoll isolation of mononuclear cells, still   <  1% of the cells were 
B cells. The other samples had   ≥  20% CD19  +   cells and thus were not further purifi  ed. Data are from one donor representative of three.     2036 T CELL  –  INDEPENDENT DEVELOPMENT OF IGM  + IGD + CD27 +   B CELL IN HUMAN FETUS   | Scheeren et al. 
HIS (BALB-Rag/    ) mice, mRNA was isolated, and an RT-
PCR specifi  c for V  H  3-C     was performed. Sequencing of the 
cloned PCR products revealed that approximately half of 
the sequences from the CD19  +  IgD  +  CD27  +   cells contained 
SHMs (Table II).   These data demonstrate that the human 
IgD  +  CD27  +   B cells in the HIS (BALB-Rag/    ) mice have un-
dergone SHMs. 
model in which development of the human immune system 
(HIS) can be studied (  26, 27  ). We used alymphoid Rag2      /      
    c      /      mice (  28  ) to monitor the development of human 
IgD  +  IgM  +  CD27  +   B cells. To this end, we injected sorted 
CD34  +  CD38    –   lineage    –    fetal liver HSCs into sublethally irra-
diated newborn BALB/c Rag2      /          c      /      mice. After 6  –  8 wk, 
the resulting HIS (BALB-Rag/    ) mice showed a robust re-
constitution by human cells, including T cells, B cells, and 
plasmacytoid DCs in the diff  erent lymphoid organs (  27, 29  ). 
The level of human reconstitution, as indicated by the fre-
quency of huCD45  +   cells, ranged from 30 to 90% in periph-
eral blood of HIS (BALB-Rag/    ) mice, with a large majority 
of human CD19  +   B cells (Fig. S5, A and B, available at 
http://www.jem.org/cgi/content/full/jem.20070447/DC1). 
Most reconstituted Rag2      /          c      /      mice (  >  10% huCD45  +  ) 
contained both human IgM and IgG in their serum (Fig. S5 C), 
with titers similar to previously published observations (  26, 27  ). 
IgD  +  CD27  +   B cells could be detected in the spleen and the 
blood of HIS (BALB-Rag/    ) mice (  Fig. 2 A  ).   A more de-
tailed phenotype of splenic IgD  +  CD27  +   B cells showed that 
they were sIgM  +  CD21  high  CD1c  +   (  Fig. 2 B  ), i.e., they were 
similar to MZ B cells found in the MZ and peripheral blood 
of human beings. The frequency of CD27  +   cells among 
IgD  +  CD19  +   B cells was around 2.5 and 1% in the spleen and 
blood, respectively (  Fig. 2 C  ). The percentages found in the 
reconstituted mice are similar to the percentages found in 
young children (  13  ). 
  A detailed analysis of the anatomical structure of the spleen 
of reconstituted Rag2      /          c      /      mice (  n   = 12) failed to 
reveal MZ structures (not depicted) despite the presence 
of IgM  +  IgD  +  CD27  +   B cells in the circulation and peripheral 
organs. This suggests that there is a disconnection between the 
anatomical MZ structure in the spleen and the presence of 
IgD  +  CD27  +   B cells. Similarly, in children under the age of 2 yr, 
IgM  +  IgD  +  CD27  +   B cells can be found in the peripheral blood 
despite the absence of anatomical MZ structure (  13, 16  ). 
  To determine whether the IgD  +  IgM  +  CD27  +   B cells, which 
developed in the repopulated HIS (BALB-Rag/    ) mice, also 
had undergone SHMs we sequenced V  H  3-C     heavy chain re-
gions derived from these cells. Splenic CD19  +  IgD  +  CD27  +   and 
CD19  +  IgD  +  CD27    –    cells were sorted from three independent 
  Table I.      IgH SHM analysis of fetal spleen B cells 
  B cells    Total unique sequences    Mutated sequences        a       % of mutation frequency        b       Mutation range 
Donor 1 
  IgD  +  CD27      
11 0       
Donor 1 
  IgD  +  CD27  + 
18 3 (17%) 2.3 5  –  7
Donor 2 
  IgD  +  CD27  + 
19 3 (16%) 2.7 5  –  11
Donor 3 
  IgD  +  CD27  + 
29 6 (21%) 2.4 3  –  12
  a    Only unique rearrangements were considered for analysis. Sequences scored as mutated contained three or more mutations (  ≥  1% mutation frequency). In brackets is the 
frequency of mutated sequences among all sequences.
  b    The percentage of point mutations among the total number of sequenced nucleotides of mutated sequences.
    Figure 2.         Human B cells with MZ B cell phenotype are present in 
HIS (BALB-Rag/    ) mice.   (A) Flow cytometry analysis of blood and 
spleen lymphocytes of the human HSC-reconstituted Rag2   – / –      c  – / –    mice. 
The sIgD-CD27 dot plots were obtained after gating on CD45  +   and 
CD19  + CD3       cells, as indicated by the outlined areas. (B) Expression of 
sIgM, CD21, and CD1c by CD19  + sIgD + CD27       cells (thin line) and 
CD19  + sIgD + CD27 +   cells (bold line) from the spleens of HIS (BALB-Rag/   ) 
mice. Dotted lines represent staining with the matched isotype control. 
(C) Percentage of CD27    +    cells within the CD19  + sIgD +   population in the 
spleen and the blood of HIS (BALB-Rag/    ) mice. Data were obtained from 
12 reconstituted Rag2   – / –      c  – / –    mice with human HSC s isolated from fi  ve 
independent donors.     JEM VOL. 205, September 1, 2008 
ARTICLE
2037
  Development of IgD  +  CD27  +   B cells and induction of SHMs 
can occur in a T cell  –  independent manner 
  To determine whether development of IgD  +  CD27  +   B cells is 
strictly dependent on the presence of T cells, we made use of 
Rag2      /          c      /      mice on a   Nude   background. These mice have 
no functional thymus, and therefore T cell development can-
not take place (  31, 32  ). HIS (BALB-  nude  -Rag/    ) mice showed 
a similar level of human engraftment in peripheral blood than 
control HIS (BALB-Rag/    ) mice (Fig. S5, A and B). In con-
trol HIS (BALB-Rag/    ) mice, a functional mouse thymus was 
present and fully supported human T cell development, leading 
to colonization of peripheral lymphoid organs by mature 
human T cells (  Fig. 4 A  ).   In contrast, no T cells could de detected 
in the diff  erent lymphoid organs of HIS (BALB-  nude  -Rag/    ) 
mice, indicating that no thymus-independent T cell develop-
ment occurs in this humanized mouse model. Nonetheless, 
IgD  +  CD27  +   B cells were present in the blood and spleen of 
HIS (BALB-  nude  -Rag/    ) mice (  Fig. 4 B  ). A more detailed 
phenotypic analysis of the splenic IgD  +  CD27  +   B cells revealed 
  IgD  +  IgM  +  CD27  +   B cells resemble MZ B cells 
  To obtain further evidence that IgD  +  CD27  +   B cells that de-
veloped in the HIS (BALB-Rag/    ) mice were MZ-like B 
cells, we made use of a genetic approach. In normal mice, 
MZ B cell development is dependent on NOTCH2, as 
NOTCH2      /      mice lack this B cell subset (  30  ). Therefore, 
we investigated whether NOTCH2 was required for human 
IgD  +  CD27  +   B cell development in HIS (BALB-Rag/    ). 
We made use of a lentiviral vector to inhibit NOTCH2 ex-
pression through short hairpin RNA (shRNA) interference. 
The NOTCH2-specifi  c shRNA lentiviral vector induced a 
60% reduction of NOTCH2 mRNA levels as determined 
by RT-PCR in the B cell line Raji (Fig. S6, available at 
http://www.jem.org/cgi/content/full/jem.20070447/DC1). 
We compared the eff  ects of the NOTCH2-specifi  c shRNA 
lentiviral-transduced cells with the control shRNA lentivi-
ral-transduced cells within the same HIS (BALB-Rag/    ) 
mouse. We used two diff  erent fl  uorescent markers, YFP 
and GFP, to distinguish between the two vectors. Human 
FL CD34  +  CD38        HSCs were transduced with either a 
YFP control vector or with a GFP vector expressing the 
shRNA cassette to knock down NOTCH2. After lentiviral 
transduction, control and NOTCH2 knockdown-trans-
duced cells were mixed and injected in neonatal Rag2      /      
    c      /      mice. 8 wk later, repopulated mice were killed and 
the percentage of CD19  +  IgD  +  CD27  +   cells was determined 
in the GFP and the YFP population of the spleen. The 
ratio of YFP versus GFP was equal 8 wk after reconstitu-
tion in the HIS (BALB-Rag/    ) mice as compared with the 
original inoculum, demonstrating that there was no selec-
tion due the shRNA-mediated knockdown of NOTCH2. 
The shRNA-mediated knockdown of NOTCH2 resulted 
in a 50% reduction of CD19  +  IgD  +  CD27  +   cells as compared 
with the control-transduced cells (  Fig. 3 A  ) and the non-
transduced cells (not depicted).   Importantly the shRNA-
mediated NOTCH2 knockdown did not result in decreased 
frequency of other immune cell subsets, e.g., CD3  +   T cells 
(  Fig. 3 B  ), showing the specifi  city of the developmental 
block. These data strongly suggest that in humans, NOTCH2 
is important for the development of IgM  +  IgD  +  CD27  +   
B cells. 
  Table II.      IgH somatic hyper mutation analysis of spleen B cells of HIS (BALB- Rag/   )  mice 
  B cells    Total unique sequences    Mutated sequences        a       % of mutation frequency        b       Mutation range 
Donor 1 
  IgD  +  CD27      
20 0     0  –  2
Donor 1 
  IgD  +  CD27  + 
15 10 (67%) 2.6 3  –  14
Donor 2 
  IgD  +  CD27  + 
18 8 (44%) 3.1 3  –  16
Donor 3 
  IgD  +  CD27  + 
10 4 (40%) 4.5 4  –  18
  a    Only unique rearrangements were considered for analysis. Sequences scored as mutated contained three or more mutations (  ≥  1% mutation frequency). In brackets is the 
frequency of mutated sequences among all sequences.
  b    The percentage of point mutations among the total number of sequenced nucleotides of mutated sequences.
    Figure 3.         NOTCH2 is essential for development of CD19  +  sIgD  + 
CD27        cells.   (A) The relative percentage of CD19  + sIgD + CD27 +   cells in the 
spleen of HIS (BALB-Rag/    ) mice reconstituted with human HSCs trans-
duced either with the NOTCH2 shRNA-mediated knockdown construct 
(GFP  +   cells) or a control knockdown construct (YFP  +   cells). (B) Relative 
percentage of the CD3  +   cells with the NOTCH2 shRNA-mediated knock-
down construct (GFP  +   cells) compared with the CD3  +   cells with a control 
knockdown construct (YFP  +   cells). Three HIS (BALB-Rag/   )  mice  from 
three different experiments using different donors for HSC transductions 
were analyzed. The shRNA-mediated NOTCH2 knockdown is indicated 
as  siNOTCH2.   2038 T CELL  –  INDEPENDENT DEVELOPMENT OF IGM  + IGD + CD27 +   B CELL IN HUMAN FETUS   | Scheeren et al. 
that the cells were sIgM  +  CD21  high  CD1c  +   (  Fig. 4 C  ). The per-
centages of IgD  +  CD27  +   B cells in the spleen and blood were 
similar between HIS (BALB-  nude  -Rag/    ) mice (  Fig. 4 D  ) and 
control HIS (BALB-Rag/    ) mice (  Fig. 2 C  ). From these data, 
we conclude that the development of human IgD  +  CD27  +   
B cells can occur in a T cell  –  independent manner in vivo. 
  To determine the impact of the absence of T cells on the 
induction of SHMs, we determined the frequency of clones 
carrying SHMs in the VH3-C     region in three repopulated 
HIS (BALB-  nude  -Rag/    ) mice. Sequence analysis of the 
RT-PCR product showed that     25% of these cells had un-
dergone SHMs as compared with the 50% of IgD  +  CD27  +   
B cells derived from the control HIS (BALB-Rag/    ) mice 
(Table III).   Importantly, the IgD  +  CD27  +   B cells from the 
HIS (BALB-  nude  -Rag/    ) mice that had undergone SHMs 
had similar numbers of mutations, indicating that the induc-
tion of SHMs can occur in a T cell  –  independent manner. 
    DISCUSSION   
  We report here that postrearrangement Ig diversifi  cation oc-
curs in utero in human B cells via induction of SHM. We de-
scribe that in the human fetus during weeks 14 –  18 of gestation, 
IgM  +  IgD  +  CD27  +   B cells that have undergone SHM are pre-
sent. AID expression, which is a prerequisite for the induction 
of SHM, could be detected only in the fetal liver and MLNs, 
suggesting that the induction of SHM occurs in these organs. 
In both organs, IgM  +  IgD  +  CD27  +   B cells are detected that are 
CD21  high   and CD1c  high  . One could speculate that these are 
more mature IgM  +  IgD  +  CD27  +   B cells as compared with fetal 
BM IgM  +  IgD  +  CD27  +   B cells, which express low levels of 
surface CD21 and/or CD1c. However, there are obvious lim-
itations when working with human material, making it diffi   cult 
to address the maturation status of human IgM  +  IgD  +  CD27  +   
B cells. To address the question of whether development and 
induction of SHM of IgM  +  IgD  +  CD27  +   B cells is a T cell  –
  independent process, we made use of a recently developed 
in vivo  –  humanized mouse model. We observed IgM  +  IgD  + 
CD27  +  CD21  high  CD1c  high   B cells in such HIS (BALB-Rag/    ) 
mice. These cells contained SHMs and strongly resembled 
  human MZ B cells phenotypically. 
  It is well documented that there are diff  erences between 
rodent and human MZ B cells because human MZ B cells 
recirculate and contain SHMs, unlike rodent MZ B cells 
(  5, 6, 13  –  15  ). Moreover, on an anatomical level, the spleens 
of humans and rodents are slightly diff  erent (  7  ). In contrast to 
mice, humans have an inner and outer MZ surrounded by a 
perifollicular zone, which can be directly irrigated by blood 
vessels. However, such MZ structures were not found in HIS 
(BALB-Rag/    ) mice (not depicted). This observation is in 
line with fi  ndings that in children under the age of 2 yr, no 
CD27  +   MZ B cells are present in histological sections of the 
spleen, despite the fact that IgM  +  IgD  +  CD27  +   B cells can al-
ready be found in the blood of newborns (  15  ) and, as shown 
here, in the fetus. This clearly indicates that the development 
of IgM  +  IgD  +  CD27  +   B cells does not depend on the presence 
of anatomical MZ structure. 
    Figure 4.         MZ B cells develop in the absence of T cells.   (A)  Rag2    /    
   c    /     mice on   Nude   background were reconstituted with human HSCs, 
and fl  ow cytometry analysis was performed 9 wk later to detect T cells 
(CD4, CD8, and CD3) and B cells (CD19). (B) Flow cytometry analysis of 
blood and spleen lymphocytes of HIS (BALB-  nude -Rag/   ). sIgD-CD27 dot 
plots were obtained after gating on CD45  +   and  CD19 + CD3       cells, as indi-
cated by the outlined areas. (C) Expression of sIgM, CD21, and CD1c of 
CD19  + sIgD + CD27       cells (thin line) and CD19  + sIgD + CD27 +   cells (bold line) 
on splenocytes of HIS (BALB-  nude -Rag/   ) mice. Dotted lines represent 
the staining with a matched isotype control. (D) Percentage of CD27  +   cells 
within the CD19  + sIgD +   population in the spleen and the blood lympho-
cytes of HIS (BALB-  nude -Rag/   ) mice. In total, nine HIS (BALB-  nude -Rag/  ) 
mice, which were reconstituted with HCS from three different donors, 
were analyzed.     JEM VOL. 205, September 1, 2008 
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mount a high affi   nity immune response (  34, 35  ). This process 
takes place in utero and early in life in the gut-associated lym-
phoid tissue by SHM and/or gene conversion. Our data indi-
cate that a similar process occurs in humans via induction of 
SHM during fetal life. This process most likely takes place in 
the fetal liver and fetal MLNs, as AID expression could be 
detected in these organs. The MLN is considered to be part 
of the gut-associated lymphoid tissue (  36  ). In this respect, it is 
interesting to note that in mice with a highly restricted BCR 
repertoire, SHM can be detected in B cells with an immature 
phenotype. In the absence of T cells a similar mutation fre-
quency was observed (  37  ). These data are in line with our 
fi  ndings that induction of SHM can occur in a T cell  –  inde-
pendent manner; however, in this mouse model SHM only 
occurred when the BCR repertoire was severely restricted. 
  Igs that recognize autoantigen are removed from the rep-
ertoire at two checkpoints during B cell development in the 
BM and the periphery (  38, 39  ). Recently, a third checkpoint 
against self-reactive IgM during IgM  +  CD27  +   B cell develop-
ment in humans was described (  40  ). This novel check-
point for B cell tolerance is active between the naive and 
IgM  +  CD27  +   B cells that have undergone SHM. Interest-
ingly, the data suggest that self-reactive IgM antibodies are 
removed before the onset of SHM. 
  In conclusion, here we show that in utero postrear-
rangement Ig diversifi   cation via SHM occurs in human 
IgM  +  IgD  +  CD27  +   B cells. Using a humanized mouse model, 
we furthermore show that the IgM  +  IgD  +  CD27  +   B cells 
strongly resembled MZ B cells and that development and 
  induction of SHM can occur in the absence of T cells. The 
T cell  –  independent IgM  +  IgD  +  CD27  +   B cell development 
and induction of SHM strongly suggest that classical switched 
memory B cells and IgM  +  IgD  +  CD27  +   B cells develop along 
separate pathways. 
  MATERIALS AND METHODS 
  Mice.     BALB/c Rag2      /          c      /      mice and BALB/c Rag2      /          c      /      mice on 
a   Nude   background were bred and maintained in isolators and fed autoclaved 
food and water under a protocol approved by the AMC-UVA. Repopulated 
Rag2      /          c      /      mice with cells of the HIS-(BALB-Rag/    ) mice were gen-
erated as described previously with minor changes (  27  ). In brief, newborn 
(  <  1-wk-old) Rag2      /          c      /      mice received sublethal (3.5 Gy) total body ir-
radiation with an x-ray source and were injected intra-hepatically with 0.5  –
  10  6   CD34  +   human fetal liver cells or 0.5 to 2  ×   10  6   CD34  +  CD38    –   lineage    –    human 
fetal liver cells. For the lineage depletion, we used antibodies against CD3, 
  In mice it is established that NOTCH2 is essential for MZ 
B cell development, as NOTCH2 knockout mice do not have 
MZ B cells (  30  ). Combining the in vivo human  –  mouse model 
with shRNA-mediated knockdown for NOTCH2, we estab-
lished that development of IgM  +  IgD  +  CD27  +   B cells in HIS 
(BALB-Rag/    ) mice is NOTCH2 dependent. 
  Using Rag2      /            C        /      mice on a   Nude   background, in which 
no T cell development is possible due to the lack of a functional 
thymus, we demonstrated that development and induction of 
SHMs of human IgM  +  IgD  +  CD27  +   B cells is a T cell  –  indepen-
dent process. However, the frequency of IgM  +  IgD  +  CD27  +   
B cells that had undergone SHM decreased from 40  –  67% in 
control HIS (BALB-Rag/    ) mice to 22  –  26% in HIS (BALB-
  nude  -Rag/    ) mice. Importantly, IgM  +  IgD  +  CD27  +   B cells in HIS 
(BALB-  nude  -Rag/    ) mice that had undergone SHM showed a 
similar level of mutation frequency per cell as compared with 
control HIS (BALB-Rag/    ) mice. Collectively, this indicates 
that T cells are probably involved in increasing the numbers 
of these cells, but they are not essential to induce SHM in 
IgM  +  IgD  +  CD27  +   B cells. 
  The fact that IgM  +  IgD  +  CD27  +   B cells develop during fetal 
life raises the question whether IgM  +  IgD  +  CD27  +   B cells still 
develop and undergo induction of SHM during adult life. An 
answer to this question might come from adult patients with 
rheumatoid arthritis, who have been depleted of B cells using 
an anti-CD20 antibody (  33  ). Even 2 yr after the anti-CD20 
treatment, the percentages of the IgD  +  CD27  +   B cells in these 
patients are still severely reduced as compared with healthy 
controls, suggesting that the development of IgD  +  CD27  +   
B cells is not effi   cient in adults. On the other hand, numbers of 
CD27  +   class-switched B cells are also maintained at low levels 
after anti-CD20 treatment, suggesting a general developmental 
defect in CD27  +   memory B cells not necessarily restricted to 
the IgD  +  CD27  +   B cell population. 
  We hypothesize that the development and the induction 
of SHM in IgD  +  CD27  +   B cells occurs mainly during fetal 
development and in young children. It has been shown that 
upon vaccination, IgD  +  CD27  +   B cells from adults can un-
dergo additional SHM (  5  ). It will be of interest to determine 
whether the mechanism of vaccination-induced SHM is dif-
ferent from the mechanism involved in utero. 
  Postrearrangement Ig diversifi  cation has been reported in 
several species including birds and mammals, resulting in B 
cells that are able to recognize T-independent antigens and 
  Table III.      IgH SHM analysis of spleen B cells of HIS (BALB-  nude -Rag/  )  mice 
  B cells    Total unique sequences    Mutated sequences        a       % of mutation frequency        b       Mutation range 
Donor 1 
  IgD  +  CD27  + 
32 7 (22%) 2.6 3  –  14
Donor 2 
  IgD  +  CD27  + 
34 9 (26%) 2.4 3  –  10
  a    Only unique rearrangements were considered for analysis. Sequences scored as mutated contained three or more mutations (  ≥  1% mutation frequency). In brackets is the 
frequency of mutated sequences among all sequences.
  b    The percentage of point mutations among the total number of sequenced nucleotides of mutated sequences.2040 T CELL  –  INDEPENDENT DEVELOPMENT OF IGM  + IGD + CD27 +   B CELL IN HUMAN FETUS   | Scheeren et al. 
envelope coding plasmid pMD.G; the packaging plasmid pCMVDR8.91, 
designed to provide the Gag, Pol, Tat, and Rev proteins to produce the virus 
particle; and the transfer vector pTRIPU3-E1 (  42  ). pTRIPU3-E1 has been 
modifi  ed to include the siRNA cassette from the pSUPER vector containing 
the human NOTCH2-targeting sequence 5     (  43, 44  ), and it carries the en-
hanced   GFP   or   YFP   gene driven by the elongation factor-1     promoter. 48 h 
after transfection, medium was replaced and two samples of virus were col-
lected at 24 and 48 h. The virus-containing supernatants were centrifuged for 
4 min at 1,800 rpm to remove cells and then were passed through a 0.22-mm 
fi  lter and kept at     80  °  C until use. 
  Transduction protocol.     Transduction of CD34  +   human cells was performed 
by one cycle of overnight exposure to viral supernatant on retronectin (Takara 
Shuzo, Co.) -coated 24-well plates in the absence of cytokines. The next day, 
cells were washed and injected intra-hepatically in the newborn mice. 
  IgM and IgG ELISA.     To measure Ig levels in the serum of the reconsti-
tuted mice, we performed an ELISA for IgM and IgG using the serum of the 
mice. Microtiter plates (9018; Costar) were coated with 100   μ  l/well of anti-
IgM (10   μ  g/ml goat anti  –  human polyclonal; Jackson ImmunoResearch 
Laboratories) or anti-IgG (10   μ  g/ml goat anti  –  human polyclonal; Jackson 
ImmunoResearch Laboratories) in PBS. ELISA was developed with horse-
radish peroxidase  –  labeled goat anti  –  human IgM and IgG antibodies (Dako) 
and horseradish peroxidase substrates (Sigma-Aldrich). OD  405   was measured 
with a microplate reader (MDS Analytical Technologies). 
  Online supplemental material.     Fig. S1 shows four representative IgD/
CD27 dot plots of analyzed fetal tissue. Fig. S2 shows the gestational age of 
the analyzed fetal tissue and the percentage of IgD  +  CD27  +   B cells within the 
IgD  +   B cell population. Fig. S3 shows that CD19  +  sIgD    –   CD27  +   B cells ex-
press CD34 and lack BCR expression. Fig. S4 shows that AID is expressed in 
the IgD  +   B cells of fetal liver but not in fetal BM and fetal spleen IgD  +   B cells. 
Fig. S5 shows the reconstitution effi   ciency of repopulated HIS mice, the 
percentage of CD45  +  , CD3  +  , and CD19  +   cells, and the IgG and IgM levels 
in the serum. Fig. S6 shows the knockdown effi   ciency for the NOTCH2 
shRNA-mediated knockdown construct. The online supplemental material 
is available at http://www.jem.org/cgi/content/full/jem.20070447/DC1. 
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